IP Library Granted Patent US 9,192,715
Granted Patent B2
US 9,192,715 · App. 14/221,536 · Granted Nov 24, 2015

Methods for renal nerve blocking

Inventors: Mark Gelfand (New York, NY); Howard R. Levin (Teaneck, NJ)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61M5/145A61K9/0012A61K9/7007A61L29/146A61M5/14276A61M5/1723A61N1/326A61N1/36114A61M2005/14513A61M2210/1082A61N1/0551A61N1/36007A61N1/3627A61N1/36117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,192,715
App. No.
14/221,536
Granted
Nov 24, 2015
Kind
B2
Abstract

A method and apparatus for treatment of cardiac and renal diseases associated with the elevated sympathetic renal nerve activity by implanting a device to block the renal nerve signals to and from the kidney. The device can be a drug pump or a drug eluding implant for targeted delivery of a nerve-blocking agent to the periarterial space of the renal artery.

Claims (29)

1. A method for treatment of a human patient diagnosed with hypertension, the method comprising:

positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve of the patient; and

delivering a nerve blocking agent via the catheter to inhibit neural traffic along the renal nerve,

wherein delivering the nerve blocking agent results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve comprises positioning the catheter near a renal hilum of the patient.

3. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve comprises positioning the catheter within a renal hilum of the patient.

4. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve comprises positioning a distal tip of the catheter within a target site in continuity with a periarterial fat tissue layer surrounding a renal pedicle of the patient.

5. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve comprises positioning a distal tip of the catheter within renal fascia of the patient.

6. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery comprises intravascularly delivering the catheter through an abdominal aorta to the renal artery of the patient.

7. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery comprises extravascularly positioning the catheter within the periarterial space.

8. The method of claim 1 wherein positioning a catheter in a periarterial space of a renal artery and proximate a renal nerve of the patient comprises delivering the catheter over a guidewire.

9. The method of claim 1 wherein the renal nerve innervates a kidney of the patient, and wherein inhibiting neural traffic along the renal nerve comprises denervating the kidney.

10. The method of claim 1 wherein inhibiting neural traffic along the renal nerve comprises ablating the renal nerve.

11. The method of claim 1 wherein delivering a nerve blocking agent via the catheter comprises delivering at least one of an anesthetic, a neurotoxin, an alcohol, and an antidepressant to the renal nerve.

12. The method of claim 1 wherein delivering a nerve blocking agent via the catheter comprises delivering an alcohol to the renal nerve.

13. The method of claim 1 wherein the catheter has a sealed tip and at least one side hole or pore through a sidewall of the catheter, and wherein delivering a nerve blocking agent via the catheter comprises delivering alcohol via the at least one side hole or pore.

14. The method of claim 1 , further comprising removing the catheter from the patient after delivering nerve blocking agent to conclude the procedure.

15. The method of claim 1 wherein inhibiting neural traffic along the renal nerve further results in a reduction of systemic sympathetic tone in the patient.

16. A method for catheter-based renal denervation of a hypertensive human patient, the method comprising:

positioning a catheter having a drug delivery element within a renal hilum of the patient and adjacent neural fibers innervating a kidney of the patient; and

at least partially ablating the neural fibers via a nerve blocking agent delivered from the drug delivery element,

wherein at least partially ablating the neural fibers results in a therapeutically beneficial reduction in blood pressure in the patient.

17. The method of claim 16 wherein positioning a catheter having a drug delivery element within a renal hilum of the patient comprises positioning the catheter within a distal portion of the renal vasculature of the patient.

18. The method of claim 16 wherein the nerve blocking agent comprises at least one of an anesthetic, a neurotoxin, an alcohol, and an antidepressant.

19. The method of claim 16 wherein the nerve blocking agent comprises an alcohol.

20. The method of claim 16 , further comprising monitoring a parameter of the catheter and/or tissue within the patient before and during delivery of the nerve blocking agent from the drug delivery element.

21. The method of claim 20 , further comprising altering delivery of the nerve blocking agent in response to the monitored parameter.

22. The method of claim 16 , further comprising removing the catheter from the patient after delivering the nerve blocking agent to conclude the procedure.

23. The method of claim 16 wherein the catheter has a sealed tip and at least one aperture through a sidewall of the catheter, and wherein at least partially ablating the neural fibers via a nerve blocking agent comprises delivering alcohol via the at least one aperture.

Continuity (7)
Continuation 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20140324016A1 · Oct 30, 2014